[HTML][HTML] Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation

J Jiang, W Lv, X Ye, L Wang, M Zhang, H Yang… - Cell research, 2013 - nature.com
Induced pluripotent stem (iPS) cells generated using Yamanaka factors have great potential
for use in autologous cell therapy. However, genomic abnormalities exist in human iPS cells …

[HTML][HTML] Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation

J Jiang, W Lv, X Ye, L Wang, M Zhang, H Yang… - Cell …, 2013 - ncbi.nlm.nih.gov
Induced pluripotent stem (iPS) cells generated using Yamanaka factors have great potential
for use in autologous cell therapy. However, genomic abnormalities exist in human iPS cells …

Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.

J Jiang, W Lv, X Ye, L Wang, M Zhang, H Yang… - Cell …, 2012 - europepmc.org
Induced pluripotent stem (iPS) cells generated using Yamanaka factors have great potential
for use in autologous cell therapy. However, genomic abnormalities exist in human iPS cells …

[引用][C] Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation

J Jiang, W Lv, X Ye, L Wang, M Zhang, H Yang… - Cell Research, 2012 - cir.nii.ac.jp
Zscan4 promotes genomic stability during reprogramming and dramatically improves the
quality of iPS cells as demonstrated by tetraploid complementation | CiNii Research CiNii 国立 …

Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.

J Jiang, W Lv, X Ye, L Wang, M Zhang… - Cell …, 2013 - search.ebscohost.com
Induced pluripotent stem (iPS) cells generated using Yamanaka factors have great potential
for use in autologous cell therapy. However, genomic abnormalities exist in human iPS cells …

Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation

J Jiang, W Lv, X Ye, L Wang, M Zhang, H Yang… - 2013 - kms.shanghaitech.edu.cn
Zscan4 stabilized the genomic DNA, resulting in p53 downregulation. Furthermore, Zscan4
also enhanced telomere lengthening as early as 3 days post-infection through a telomere …

Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation

J Jiang, W Lv, X Ye, L Wang, M Zhang… - Cell …, 2013 - pubmed.ncbi.nlm.nih.gov
Induced pluripotent stem (iPS) cells generated using Yamanaka factors have great potential
for use in autologous cell therapy. However, genomic abnormalities exist in human iPS cells …

[PDF][PDF] Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation

J Jiang, W Lv, X Ye, L Wang, M Zhang, H Yang… - Cell …, 2013 - researchgate.net
Zscan4 stabilized the genomic DNA, resulting in p53 downregulation. Furthermore, Zscan4
also enhanced telomere lengthening as early as 3 days post-infection through a telomere …

Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.

J Jiang, W Lv, X Ye, L Wang, M Zhang, H Yang… - Cell …, 2012 - europepmc.org
Induced pluripotent stem (iPS) cells generated using Yamanaka factors have great potential
for use in autologous cell therapy. However, genomic abnormalities exist in human iPS cells …

Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.

J Jiang, W Lv, X Ye, L Wang, M Zhang… - Cell …, 2013 - search.ebscohost.com
Induced pluripotent stem (iPS) cells generated using Yamanaka factors have great potential
for use in autologous cell therapy. However, genomic abnormalities exist in human iPS cells …